Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in
patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia …

Direct oral anticoagulants (DOACs) have largely replaced vitamin K antagonists, mostly
warfarin, for the main indications for oral anticoagulation, prevention and treatment of …

Patients with cancer are characterized by a dysregulation of the hemostatic system and
systemic hypercoagulability. Different components of the hemostatic system are involved in …

Venous thromboembolism (VTE) is often associated with malignant diseases and notably
contributes to morbidity and mortality in patients with cancer. Cancer‐associated thrombosis …

The rising incidence and persistent thrombosis in multiple cancers including those that are
immunosuppressive highlight the need for understanding the tumor coagulome system and …

Venous thromboembolism (VTE) is the most fatal complication in cancer patients.
Unfortunately, the frequent misdiagnosis of VTE owing to the lack of accurate and efficient …

Pancreatic cancer is currently the third leading cause of cancer death in the United States.
The clinical hallmarks of this disease include abdominal pain that radiates to the back, the …

We conducted a prospective cohort study to examine the associations of 21 gastrointestinal
diseases with the risk of incident venous thromboembolism (VTE). The study included 485 …

Among cancer patients, thrombosis and cachexia are major causes of morbidity and
mortality. Although the two may occur together, little is known about their possible …

Cancer progression impacts and exploits the vascular system in several highly
consequential ways. Among different types of vascular cells, blood cells and mediators that …